Nurix Therapeutics, Inc.

Isabel Morgado, PhD

Dr. Isabel Morgado is working as a Scientist I at Nurix Therapeutics. She received her Ph.D. in Molecular Biology from the University of Algarve in Portugal,…

Subscribe to

RNAi Explained

Dr. Bersell explores RNA interference (RNAi) technology and its applications in treating ATTR-CM and ATTR-PN. Learn about mechanism of action, clinical evidence, and patient outcomes.

Learn More

Expert Perspectives on Attruby®

Dr. Barry Trachtenberg and ATTR community members discuss Attruby™ (acoramidis), covering clinical data, patient perspectives, and treatment considerations.

Watch Discussion